General Biologicals Corporation (TPEX:4117)

General Biologicals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	243.34	251.65	217.12	262.18	308.77
Short-Term Investments	391.41	-	-	88.9	60
Cash & Short-Term Investments	634.75	251.65	217.12	351.08	368.77
Cash Growth	152.24%	15.90%	-38.16%	-4.80%	-22.13%
Accounts Receivable	68.8	43.2	84.36	57.18	42.31
Other Receivables	2.78	28.18	0.72	4.32	5.17
Receivables	71.58	71.38	85.09	61.5	47.49
Inventory	58.95	57.08	85.56	116.79	81.32
Prepaid Expenses	22.15	82.87	-	18.33	11.56
Other Current Assets	5.19	3.72	14.09	3.28	1.18
Total Current Assets	792.62	466.69	401.85	550.97	510.32
Property, Plant & Equipment	829.1	2,819	2,002	864.46	607.87
Long-Term Investments	409.07	40.45	38.16	36.68	38.52
Goodwill	21.61	21.61	20.68	20.68	20.68
Other Intangible Assets	30.51	32.71	36.19	41.09	44.58
Long-Term Accounts Receivable	15.63	53.49	-	-	-
Long-Term Deferred Tax Assets	-	-	-	11.93	18.91
Other Long-Term Assets	2,771	45.16	37.96	24.77	23.58
Total Assets	4,870	3,479	2,537	1,551	1,264

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	61.21	43.02	24.26	25.3	38.74
Accrued Expenses	28.48	19.24	18.51	12.2	12.95
Short-Term Debt	60	60	50	5	-
Current Portion of Long-Term Debt	58.88	41.04	1.59	1.57	3.24
Current Portion of Leases	8.6	107.67	117.73	10.1	7.75
Current Income Taxes Payable	3.61	-	-	-	-
Current Unearned Revenue	85.79	25.69	6.48	5.82	3.83
Other Current Liabilities	90.43	108.94	810.73	38.05	10.56
Total Current Liabilities	397	405.6	1,029	98.04	77.07
Long-Term Debt	1,966	1,697	33.54	0.13	1.71
Long-Term Leases	402.43	404.2	345.6	452.02	436.74
Long-Term Unearned Revenue	1,141	635.32	620.7	-	-
Pension & Post-Retirement Benefits	-	-	-	0.02	0.95
Long-Term Deferred Tax Liabilities	45.28	4.6	4.9	6.19	5.48
Other Long-Term Liabilities	45.06	46.35	6.65	301.11	7.84
Total Liabilities	3,997	3,193	2,041	857.51	529.79

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	708.25	608.25	598.25	598.25	598.25
Additional Paid-In Capital	122.85	99.28	87.8	87.8	87.8
Retained Earnings	36.95	-428.4	-207.03	-8.23	44.05
Comprehensive Income & Other	2.65	5.46	16.12	12.71	1.42
Total Common Equity	870.69	284.59	495.13	690.52	731.51
Minority Interest	1.78	1.9	1.51	2.55	3.14
Shareholders' Equity	872.47	286.48	496.65	693.07	734.66
Total Liabilities & Equity	4,870	3,479	2,537	1,551	1,264

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	2,496	2,310	548.46	468.82	449.44
Net Cash (Debt)	-1,862	-2,058	-331.34	-117.74	-80.66
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-29.74	-34.40	-5.54	-1.97	-1.35
Filing Date Shares Outstanding	70.83	60.83	59.83	59.83	59.83
Total Common Shares Outstanding	70.83	60.83	59.83	59.83	59.83
Working Capital	395.62	61.09	-627.45	452.94	433.25
Book Value Per Share	12.29	4.68	8.28	11.54	12.23
Tangible Book Value	818.57	230.26	438.27	628.76	666.26
Tangible Book Value Per Share	11.56	3.79	7.33	10.51	11.14
Buildings	583.66	50.02	50.02	49.85	49.86
Machinery	197.77	194.1	189.38	174.16	171.07
Construction In Progress	81.01	2,210	1,415	263.91	1.77
Leasehold Improvements	11.31	20.13	20.13	20.13	20.13

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 27, 2026

Data Sources Report a data error